NEW YORK (Reuters Health) - A test vaccine against Campylobacter jejuni, a major cause of traveler’s diarrhea, provided protection against infection in mice and monkeys and may ultimately have human application, according to researchers.
NEW YORK (Reuters Health) - A test vaccine against Campylobacter jejuni, a major cause of traveler’s diarrhea, provided protection against infection in mice and monkeys and may ultimately have human application, according to researchers.
